J&J’s Imaavy wins label expansion; Two approvals in Japan

RegulatoryapprovedImaavyPositive

AI Analysis

Summary

J&J's Imaavy received label expansion approval becoming the first treatment specifically approved for warm autoimmune hemolytic anemia. The approval also includes two approvals in Japan.

Outcome Details

Label expansion approved for warm autoimmune hemolytic anemia; first treatment specifically approved for this indication

Importance:7/10

Sentiment:

0.80

FDA approvallabel expansionmonoclonal antibodyrare diseaseJapan approval

Related Companies

$JNJ

Read the original article

Published by Endpoints News on August 25, 2026 2:44 PM

Read Original